Cal-27 Cells
Cal-27 Cells - Related Videos
08:34
RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing
0 Views •
Cited by 3 •
2016
Herein, we present a protocol to use heat shock protein 27 (HSP27)-specific small interfering RNA to assess the function of HSP27 during corneal epithelial wound healing. RNA interference is the best method for effectively knocking-down gene expression to investigate protein function in various cell types.
11:37
Measuring Calpain Activity in Fixed and Living Cells by Flow Cytometry
0 Views •
Cited by 6 •
2010
This article will detail the protocol for measuring calpain activity in fixed and living cells using flow cytometry.
08:02
Determination of Immune Cell Identity and Purity Using Epigenetic-Based Quantitative PCR
0 Views •
Cited by 1 •
2020
Here we describe a robust method of determining immune cell identity and purity through epigenetic signatures detected using quantitative PCR (qPCR). DNA demethylation at a specific locus serves as a unique identifier for a particular cell type and allows for identification of CD8+, regulatory, or Th17 T cells.
09:30
Imaging Local Ca2+ Signals in Cultured Mammalian Cells
0 Views •
Cited by 17 •
2015
Here we present techniques for imaging local IP3-mediated Ca2+ events using fluorescence microscopy in intact mammalian cells loaded with Ca2+ indicators together with an algorithm that automates identification and analysis of these events.
12:03
Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
0 Views •
Cited by 15 •
2011
A comprehensive overview of the techniques involved in generating a mouse model of oral cancer and quantitative monitoring of tumor invasion within the tongue through multi-photon microscopy of labeled cells is presented. This system can serve as a useful platform for the molecular assessment and drug efficacy of anti-invasive compounds.
FAQs
Cal-27 cells provide a controlled in vitro setting for connecting observable tumor-cell behavior with molecular changes. Their proliferation can be measured alongside gene-expression analyses, allowing investigators to examine whether altered growth accompanies shifts in cellular programs. This combination helps link phenotype and mechanism, rather than treating viability or growth as isolated outcomes.
Comparisons with normal cells or other cancer models help determine whether an observed response is characteristic of malignant oral-cell behavior or reflects a broader feature of cultured cells. This context strengthens interpretation of viability, migration, invasion, or treatment data and helps researchers judge how confidently a finding can inform oral cancer biology.
Therapy resistance can be investigated by examining how Cal-27 cells respond to experimental treatments and by pairing response measurements with gene-expression analysis. Differences in viability or growth-associated behavior may then be considered alongside molecular changes, helping identify mechanisms associated with reduced treatment effectiveness. This makes the model useful for studying both drug sensitivity and resistance.
Using several readouts gives a broader picture of how an experimental condition affects the cells. Viability addresses survival, migration and invasion assays examine distinct tumor-associated behaviors, and gene-expression analysis provides molecular context. Interpreting these measurements together can distinguish a general reduction in cell performance from a more specific change in behavior or signaling.
A basic workflow begins by maintaining the adherent cells under controlled in vitro conditions, followed by the experimental manipulation appropriate to the research question. Investigators can then select assays for viability, migration, invasion, or gene expression and compare the resulting measurements across conditions. This sequence connects treatment or pathway changes with measurable cellular outcomes.
In cancer research, the model can be used to test hypotheses about tumor biology, signaling pathways, drug sensitivity, and therapy resistance. Its results become more informative when paired with comparisons involving other models or normal cells. Such designs help prioritize findings that may support development of more effective oral cancer therapies.